<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">5230</item><item key="factors"><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec1-II"><item key="Dose">  </item><item key="Treatment">none</item><item key="Compound">none</item></item></item><item><item key="Huvec4-II"><item key="Dose">  </item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">none</item></item></item><item><item key="Huvec4-II"><item key="Dose">  </item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">none</item></item></item><item><item key="Huvec4-II"><item key="Dose">  </item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">none</item></item></item><item><item key="Huvec4-II"><item key="Dose">  </item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">none</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec2-II"><item key="Dose">5</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec6-II"><item key="Dose">5</item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec6-II"><item key="Dose">5</item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec6-II"><item key="Dose">5</item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec6-II"><item key="Dose">5</item><item key="Treatment">erythrocytes infected with Plasmodium falciparum ItG</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec7-II"><item key="Dose">10</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec7-II"><item key="Dose">10</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec7-II"><item key="Dose">10</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item><item><item key="Huvec7-II"><item key="Dose">10</item><item key="Treatment">none</item><item key="Compound">tumor necrosis factor alpha</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Sensitisation of endothelium to TNFalpha induced by cytoadherence of Plasmodium falciparum infected red blood cells</item><item key="pubmed_id">17383656</item><item key="geo_gse_id">E-SGRP-3</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">28</item><item key="tags"><item>endothelium</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-by-array-of-human-endoth-2</item><item key="geo_id_plat">E-SGRP-3_A-AFFY-44</item><item key="name">Transcription profiling by array of human endothelial cells after treatment with erythrocytes infected with Plasmodium falciparum and/or TNF-alpha</item><item key="created">Sep.22, 2014</item><item key="summary">Sensitisation of endothelium to TNFalpha induced by cytoadherence of Plasmodium falciparum infected red blood cells</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-SGRP-3</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-SGRP-3/samples/</item></data></biogps>
